On the morning of June 29, 2023, Xu Jun, chairman of Tengzhou Xinhua Investment Group, and other three people came to our company to visit and negotiate.

The plant capsule is a coat that wraps the drug, the purpose is to make the drug easier to take, to achieve the best effect.
In the practical application of plant capsules, pharmaceutical companies generally print logos on the surface of capsules, such as trademark letters, trademark names or drug names, in order to facilitate product identification, protect their own brands and prevent counterfeiting.

On June 30, 2023, Dayou Shuoneng Industrial Co., Ltd. and Shanghai Tsuen Jikang Pharmaceutical Technology Co., Ltd. held a signing ceremony in Beijing Dayou Building. Dayou Group will fully support Tsuen Jikang to create a segmented leader in the field of pharmaceutical supplements, increase the well-being of the people, and present a gift for the Party's birthday. Dayou Shuoneng chairman An Sha, general manager Song Yunqiang, Tsuen Jikang chairman Liu Naiyu, China Industrial Development Research Institute President CAI Hongbing, vice president Fei Hong attended the signing ceremony.

July 6, 2023, Bozhou City Qiaocheng District Song Baozhong District mayor and other 4 people to visit our company to negotiate.

Recently, Unicorn pharmaceutical excipients hydroxypropyl methylcellulose hollow capsule successfully passed the technical evaluation and obtained the registration number F20210000442 in the Drug Evaluation Center (CDE) of the State Drug Administration. According to the CDE website, the joint review and approval result of our company's pharmaceutical excipients hydroxypropyl methylcellulose hollow capsules and preparations is A. The plant capsule is especially suitable for use in the capsules of Chinese and Western medicine factories and health products factories, and is the best replacement for gelatin capsules.

On July 16, 2023, Fan Xiaoyang, deputy mayor of Tengzhou City Government of Shandong Province, Xu Jun, Party secretary and chairman of Tengzhou Xinhua Investment Group, Liu Hao, deputy general manager of Tengzhou Xinhua Investment Group, chairman of Shandong Xinhua Financial Investment Holding Company, and Gaisu, general manager of Guoxin Guoxin Investment Management Co., Ltd. visited our Hebei Langfang demonstration production base.

On July 17, 2023, Ding Guozhen, secretary of the Party Working Committee and director of the Management Committee of Wuwei Industrial Park in Gansu Province, and other three people visited our demonstration production base in Langfang, Hebei.

Today, Zhu Shoujiang, Deputy Secretary of the Party Group and Deputy Director of the Standing Committee of Xiangyang Municipal People's Congress, Li Shaoping, Director of Xiangyang Municipal Health Care Commission, Hu Xiaolan, Standing Committee Member and Executive Vice Mayor of Xiancheng District, Liu Yinghao, Standing Committee Member and Minister of United Front Work of Xiancheng District, and other 6 people came to our Shanghai headquarters for a visit.

As a high-tech enterprise focusing on the manufacture of "plant hollow capsules", our company is a natural medicinal excipient, extracted from plants without any animal ingredients, which can meet the needs of people with vegetarian culture and special religious groups such as Muslims and Jews. At the same time, it has the advantages of good universality, stable physical and chemical properties, no chemical residues, no bacterial microbial contamination, etc. It is widely used in the fields of drugs, health care products and nutritional supplements, and is very suitable for the filling of Chinese medicine preparations and biological preparations.

In the international pharmaceutical industry chain restructuring, drug research and development and manufacturing of some parts of the trend of continuous transfer to developing countries, China has become a key area of global pharmaceutical industry transfer due to its cost advantage, sufficient professional and technical personnel, rich production experience, and huge market potential. Therefore, the future expansion of the scale of preparation production will certainly drive the growth of China's pharmaceutical excipients market demand, and the growth of new pharmaceutical excipients will be more rapid.